Newbury Park, CA, United States of America

Robin L Elliott

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
3 patents (USPTO):

Title: The Innovations of Robin L Elliott

Introduction

Robin L Elliott is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents to his name, Elliott's work has had a profound impact on medical treatments.

Latest Patents

Elliott's latest patents focus on human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors. These patents detail the creation of monoclonal antibodies and hybridomas that interact with osteoprotegerin ligand (OPGL). Additionally, he has developed methods for treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL. Furthermore, his patents include methods for detecting the amount of OPGL in a sample using antibodies to OPGL.

Career Highlights

Throughout his career, Elliott has worked with prominent companies in the biotechnology sector, including Amgen Inc. and Medarex Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Elliott has collaborated with notable individuals in his field, including William James Boyle and Eugene Medlock. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Robin L Elliott's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of treatments for osteopenic disorders and the detection of OPGL.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…